EndoChoice expects $18.6M in Q4 revenue

EndoChoice has released its unaudited, preliminary financial results for the fourth quarter and full year of 2015.

The scope maker expects to report $18.6 million in total revenue for the fourth quarter, up from $18.3 million in the fourth quarter of 2014. Revenue for the full year is predicted to be $72.3 million, up 18 percent from $61.4 million in 2014.

The company's fourth quarter revenue consisted of:

•    Imaging: $5.2 million
•    Single-use products: $9.5 million
•    Pathology: $3.9 million

EndoChoice shipped 25 of its Fuse Endoscopy systems during the fourth quarter of 2015, and a total of 99 were shipped for the full year. The company will report its full fourth quarter and full year financial results March 3.

More articles on gastroenterology:
Dr. Lawrence Kosinski's SonarMD partners with Digestive Health Center of New Jersey
FDA clears 51 GI/endoscopy devices in 2015
Exact Sciences expects to double number of Cologuard tests completed in 2016

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months